Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
Alberta Stroke Program Early CT score
algorithm
amaurosis fugax
andexanet
aneurysm
aneurysm, anterior communicating
aneurysm, internal carotid artery
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
aneurysm, middle cerebral artery
aneurysm, multiple intracranial
aneurysm, vertebral basilar system
angiography, cerebral
anticholesterolemic agents in treatment of C.V.D.
anticoagulant, complications of
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
aortoiliac reconstruction
arterial dissection
arteritis, temporal
aspirin
asymptomatic
basal ganglia, hemorrhage
blood pressure
blood pressure, control
brain scan
bruit
bruit, asymptomatic
calcium antagonist
carotid artery disease
carotid artery occlusion, neck
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, cerebrovascular disease
CAT scan, dense artery sign
CAT scan, mass effect on
CAT scan, perfusion
cerebellar hemorrhage
cerebral atherosclerosis
cerebral blood flow
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral ischemia, pathogenesis of
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to treatment
cerebrovascular disease
cerebrovascular disease, cardiovascular disease with
cerebrovascular disease, hypercholesterolemia in
cerebrovascular disease, predisposed factor in
cerebrovascular disease, smoking in
cerebrovascular disease, surgical treatment of
cerebrovascular disease, treatment of
ciraparantag
collateral circulation
complications
controversies in neurology
coronary artery bypass
coronary thrombolysis
coumarin
craniectomy, decompressive
critical care unit
dabigatran
danaproid
dense middle cerebral artery sign
dextran
diabetes mellitus
dipyridamole
disability, neurological
do not resuscitate
echoencephalogram
electroencephalogram
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endovascular therapy
endovascular therapy, futile interhospital transfer
endovascular therapy, selection criteria
ENRICH trial
epidemiology of neurology
excitotoxin
factor Xa inhibitor
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gastrointestinal bleeding
Glasgow coma score
glutamic acid
head injury
headache
hemodynamics, regional after stroke
hemostatic therapy
heparin
heparin, low-molecular-weight
heparinoid, low molecular weight
herniation syndromes, intracranial
hydrocephalus
hyperglycemia
hypertension
iatrogenic neurologic disorders
idarucizumab
incidence
INR values
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, multiple
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
intracranial pressure, increased
intravascular volume expansion
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
intubation
ischemic penumbra
life support, withdrawal of
life support, withholding of
lumbar puncture
lumbar puncture, complications of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, treatment of
Marfan syndrome
metabolic change after ischemic cerebral infarct
middle cerebral artery, occlusion of
minimally invasive surgery
mortality
MRI, CAT scan compared to
multimodal neuroimaging
myocardial infarction
myocardial infarction, acute
neurologic disease, diagnoses of
neurologic examination
neurological intensive care
neuroprotective agents
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
old age, neurology of
ophthalmodynamometry
orthostatic hypotension
patient selection
platelet inhibiting drugs
postpartum cerebral angiopathy
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
race
RAPID CT perfusion maps
recombinant activated factor VII
review article
risk factors
seizure
seizure, prevention of
small vessel disease
Spot sign
steroid
steroid therapy, CNS treatment and complications with
streptokinase
stroke center
stroke protocol
stroke, completed
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subdural hematoma
superficial temporal-middle cerebral artery anastomosis
syncope
thrombectomy
thrombocytosis
thrombolysis, mechanical
thrombosis, cerebral
ticlopidine
time is brain
tissue plasminogen activator, intravenous
tranexamic acid
transient global amnesia
transient ischemic attack
transient ischemic attack, crescendo
transient ischemic attack, treatment of
transport of patient
treatment of neurologic disorder
vasculopathy
vasodilating agents in treatment of cerebrovascular disease
vasospasm, cerebral
ventriculostomy
ventriculostomy, endoscopic
vertebral-basilar insufficiency
vitamin K
workup
Showing articles 1200 to 1250 of 10768 << Previous Next >>

DAWN: Thrombectomy Effective Up to 24 Hours after Stroke
Medscape May, Hughes, S., 2017

Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke
Ann Neurol 81:849-856, Lansberg, M.G.,et al, 2017

Intravenous Immune Globulin: Adverse Effects
UptoDate June, Perez, E.E. & Silvergleid, A.J., 2017

Lumbar Puncture Test in Normal Pressure Hydrocephalus: Does the Volume of CSF Removed Affect the Response to Tap?
AJNR 38:1456-1460, Thakur, S.K., et al, 2017

TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity
AJNR 38:1391-1398, Lecler, A.,et al, 2017

Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017

Trial of Tocilizumab in Giant-Cell Arteritis
NEJM 377:317-328,385, Stone, J.H.,et al, 2017

A Demure Teenager and Her Dystonic Foot
Neurol 89:e71-e75, Cullinane, P.W.,et al, 2017

Quality Improvement in Neurology: Inpatient and Emergency Care Quality Measure Set
Neurol 89:730-735, Josephson, S.An.,et al, 2017

Long-Term Antithrombotic Treatment in Intracranial Hemorrhage Survivors with Atrial Fibrillation
Neurol 89:687-696, Korompoki, E.,et al, 2017

Effect of Gluten-Free Diet on Cerebellar MR Spectroscopy in Gluten Ataxia
Neurol 89:705-709, Hadjivassiliou, M.,et al, 2017

Migraine
NEJM 377:553-561, Charles, A., 2017

Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
NEJM 377:411-414, Goodman, C.W. & Brett, A.S., 2017

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
NEJM 377:431-441, Pollack, C.V.,et al, 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017

Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017

Neuroimaging Changes in Menkes Disease, Part 1
AJNR 38:1850-1857, Manara, R.,et al, 2017

Intracranial Meningeal Enhancement Characterization
Rev Colomb Radiol 28:4709-4716, Mera, J.L.C.,et al, 2017

Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017

Posterior Ischemic Optic Neuropathy
UptoDate Aug, Tamhankar, M. & Volpe, N., 2017

Retropharyngeal Abscess
Emedicine.medscape.com Jan, Kahn, J.H. & Shlamovitz, G.Z., 2017

Idiopathic Hyperammonemia after Solid Organ Transplantation: Primarily a Lung Problem? A Single-Center Experience and Systematic Review
ClinTransplant 31:e12957, Krutsinger, D.,et al, 2017

Neuropsychiatric Involvement of Behcets Disease
www.SMGEbooks.com Dec, Soyak, M., 2017

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis
JAMA Neurol 74:60-66, Robeson, K.R.,et al, 2017

Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017

A Woman in her 40s with Headache and New-Onset Seizures
JAMA Neurol 74:476-480, Graham, M.S.,et al, 2017

Neurological Autoantibody Prevalence in Epilepsy on Unknown Etiology
JAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017

Association of Spinal Manipulative Therapy with Clinical Benefit and Harm for Acute Low Back Pain
JAMA 317:1451-1460,1418, Paige, N.M.,et al, 2017

Long-Term Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurol 74:459-469,392, Muraro, P.A.,et al, 2017

Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 antibodies
Lancet 389:1367-1368, Vale, T.C.,et al, 2017

Acute Spinal Cord Compression
NEJM 376:1358-1369, Ropper, A.E. & Ropper, A.H., 2017

Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke
NEJM 376:1341-1349, Van Den Berg, L.A.,et al, 2017

Reversible Gait Ataxia
Neurol 88:e145-e149, Abkur, T.M. & Bede, P., 2017

Reduction in Time to Treatment in Prehospital Telemedicine Evaluation and Thrombolysis
Neurol 88:1305-1312, Taqui, A.,et al, 2017

Intracranial Dural Arteriovenous Fistulae
Stroke 48:1424-1431, Reynolds, M.R.,et al, 2017

Arteriovenous Malformations of the Brain
NEJM 376:1859-1866, Solomon, R.A. & Connolly, E.S., 2017

Man with Recurrent Paralysis and Cerebral White Matter Lesions
JAMA Neurol 74:599-600, Xiao, F., 2017

More to Atherosclerosis Than Stenosis
Stroke 48:e104-e107, Rai, S.,et al, 2017

Outcome of Intracerebral Hemorrhage Associated with Different Oral Anticoagulants
Neurol 88:1693-1700,1686, Wilson, D.,et al, 2017

Lithium-Induced Reversible Pisa Syndrome
Neurol 88:e184, Kumar, N.,et al, 2017

A 45-year-old man with Weakness and Myalgia after Orthopedic Surgery
Neurol 88:e185-e189, Vazquez do Campo, R.,et al, 2017

Pharmacotherapy for Diabetic Peripheral Neuropathy Pain and Quality of Life
Neurol 88:1958-1967, Waldfogel, J.M.,et al, 2017

Anticoagulant and Antiplatelet Use in Seniors with Chronic Subdural Hematoma
Neurol 88:1889-1893, Nathan, S.,et al, 2017

Restarting Anticoagulant Therapy after Intracranial Hemorrhage
Stroke 48:1594-1600, Murthy, S.B.,et al, 2017

Asymptomatic Carotid Stenosis
Neurol 88:2061-2065, Heck, D.V.,et al, 2017

Pregabalin Use Early in Pregnancy and the Risk of Major Congenital Malformations
Neurol 88:2020-2025, Patorno, E.,et al, 2017

Randomized Controlled Trial of Deutetrabenazine for Tardive Dyskinesia
Neurol 88:2003-2010, Fernandez, H.H.,et al, 2017

A 10-year-old boy with Bilateral Vision Loss
Neurol 88:e221-e224, Bulwa, Z.,et al, 2017

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Stroke 48:1416-1419, Labovitz, D.L.,et al, 2017



Showing articles 1200 to 1250 of 10768 << Previous Next >>